For more than a year, we’ve been examining the scientific evidence and speaking to the experts at the centre of the case.
Entries by BBC News
The rise of these treatments has major implications for how we think about obesity, says James Gallagher.
The rise of these treatments has major implications for how we think about obesity, says James Gallagher.
The rise of these treatments has major implications for how we think about obesity, says James Gallagher.
The rise of these treatments has major implications for how we think about obesity, says James Gallagher.
The rise of these treatments has major implications for how we think about obesity, says James Gallagher.
The rise of these treatments has major implications for how we think about obesity, says James Gallagher.
Jeannie Ambrose, one of about 1,000 affected patients, says the drug should be made available on the NHS
Jeannie Ambrose, one of about 1,000 affected patients, says the drug should be made available on the NHS
Jeannie Ambrose, one of about 1,000 affected patients, says the drug should be made available on the NHS
RECOGNITION
